Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Beams logo — Detecting Cancer, Expanding Life

Beams

Detecting Cancer, Expanding Life

Founded 2021 France France 6 employees Non Equity Assistance Health Care, Medical Devices

General Information

Company Name Beams
Founded Year 2021
Location France France
Employees 6
Industries Health Care, Medical Devices
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Beams. To contact Beams, visit beams.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Beams compare?

A PDF of Beams and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Beams soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Beams

Beams is a French startup founded in 2021, with a mission to improve the accuracy of tumor resection for solid tumor treatment. The company's slogan "Detecting Cancer, Expanding Life" encapsulates its focus on developing innovative solutions for cancer surgery. Its flagship product, the TRIOP intraoperative probe, is designed to assist surgeons in precisely localizing and removing tumor residues in real-time while preserving healthy surrounding tissues. This technology is intended for health facilities with a nuclear medicine department, aiming to enhance patient quality of life. One of the key strengths of TRIOP is its independence from the specific type of cancer, as it operates based on β particles detection. This versatile functionality provides potential benefits across various cancer types. Additionally, the probe can be integrated with excision tools or suction devices, essentially transforming them into "smart devices" with enhanced capabilities. The startup recently secured a Non Equity Assistance investment on 16 February 2021, with AGORANOV as the investor. This investment signifies confidence in Beams and its potential to make a significant impact in the field of Health Care and Medical Devices. As the company continues to innovate and develop its solutions, it presents an intriguing opportunity for potential investors and stakeholders in the healthcare and technology sectors.

Business keywords: cancer treatment, oncology, intraoperative probe, tumor resection, nuclear medicine, surgical devices, biomedical devices, real-time localization, precision medicine, beta particle detection, surgical tools, patient quality of life

Services & Products

Development and commercialization of TRIOP technology for real-time detection and surgical removal of tumor tissues

Target Customers

Surgeons medical institutions cancer treatment centers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
AGORANOV
AGORANOV
16 Feb 2021

Beams Alternatives & Competitors

View All Alternatives
Beams vs
Sirius Medical
Sirius Medical The Netherlands

Moving from localization to Surgical Marker Navigation

Venture round
55 employees
Health Care, Medical Devices
Beams vs
Galil Medical Ltd.
Galil Medical Ltd.

Cryoablation of cancerous tumors and Cryosurgery

Debt Financing
5 employees
Biopharma, Health Care
Beams vs
SmartCatch
SmartCatch France

For a reliable liquid biopsy accessible to everyone

Seed
19 employees
Health Care, Health and Wellness
View all alternatives

FAQ About Beams

Detecting Cancer, Expanding Life
Beams was founded in 2021.
Beams is headquartered in France.
Beams operates in Health Care and Medical Devices. Its work centres on cancer treatment, oncology, intraoperative probe and tumor resection. Its customers include Surgeons, medical institutions and cancer treatment centers.
Beams has approximately 6 employees.
Beams has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Beams offers: Development and commercialization of TRIOP technology for real-time detection and surgical removal of tumor tissues.
Top alternatives and competitors to Beams include Sirius Medical, Galil Medical Ltd., SmartCatch, OncoRes Medical, Current Surgical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Beams and Sirius Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Beams, https://bouncewatch.com/company/beams-2, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes